Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 15/20 | 0.95 |
| ▸ | FAAH | O00519 | 8/20 | 0.71 |
| ▸ | HSP90AA1 | P07900 | 4/20 | 0.63 |
| ▸ | PKM | P14618 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.63 |
| ▸ | HTT | P42858 | 1/20 | 0.63 |
| ▸ | ATM | Q13315 | 1/20 | 0.63 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.56 |
| ▸ | BCHE | P06276 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18713 | 0.97 | MGLL (1.00) | MGLLFAAHHSP90AA1PKMALDH1A1 | |
| SCHEMBL8920586 | 0.97 | MGLL (1.00) | MGLLFAAHHSP90AA1PKMALDH1A1 | |
| Benzene SCHEMBL28088808 | 0.97 | MGLL (1.00) | MGLLFAAHHSP90AA1PKMALDH1A1 | |
| SCHEMBL30657178 | 0.95 | MGLL (0.95) | MGLLFAAHHSP90AA1PKMALDH1A1 | |
| Methane SCHEMBL28268601 | 0.95 | MGLL (0.95) | MGLLFAAHHSP90AA1PKMALDH1A1 | |
| Hydrochloric Acid SCHEMBL8536567 | 0.95 | MGLL (0.95) | MGLLFAAHHSP90AA1PKMALDH1A1 | |
| Arsenic SCHEMBL28143838 | 0.95 | MGLL (0.95) | MGLLFAAHHSP90AA1PKMALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL28183953 | 0.95 | MGLL (0.95) | MGLLFAAHHSP90AA1PKMALDH1A1 | |
| Formaldehyde SCHEMBL27804450 | 0.92 | MGLL (0.90) | MGLLFAAHHSP90AA1PKMALDH1A1 | |
| Cyanide SCHEMBL27588214 | 0.92 | MGLL (0.90) | MGLLFAAHHSP90AA1PKMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2749579-B1 | CONJUGATED DIENE POLYMER AND METHOD FOR PRODUCING SAME | ZEON CORP (JP) | 2017-11-15 | — | — | EP | disclosed |
| US-9745394-B2 | Conjugated diene polymer and method for producing same | ZEON CORPORATION (JP) | 2017-08-29 | — | — | US | disclosed |
| EP-3026069-A1 | RUTHENIUM COMPLEX | Zeon Corporation (JP) | 2016-06-01 | — | — | EP | disclosed |
| US-20160096910-A1 | CONJUGATED DIENE POLYMER AND METHOD FOR PRODUCING SAME | ZEON CORPORATION (JP) | 2016-04-07 | — | — | US | disclosed |
| US-9243100-B2 | Conjugated diene polymer and method for producing same | ZEON CORPORATION (JP) | 2016-01-26 | — | — | US | disclosed |
| US-20140350201-A1 | CONJUGATED DIENE POLYMER AND METHOD FOR PRODUCING SAME | KYOTO UNIVERSITY (JP) | 2014-11-27 | — | — | US | disclosed |
| EP-2749579-A1 | CONJUGATED DIENE POLYMER AND METHOD FOR PRODUCING SAME | Zeon Corporation (JP) | 2014-07-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160096910-A1 | CONJUGATED DIENE POLYMER AND METHOD FOR PRODUCING SAME | PCNA, TELO2, MSN | MGLL 1027/4885FAAH 2438/4885HSP90AA1 3371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.